Literature DB >> 8542759

Botulism: the present status of the disease.

C L Hatheway1.   

Abstract

The main form of human botulism throughout the world is the classic foodborne intoxication. Would botulism is very rare, and most of the documented cases have been found in the United States. While infant botulism remains rare throughout the world, it has become the most frequent form of the disease in the United States in recent years. On very rare occasions botulism results from growth and toxin production in humans other than infants. Botulism occurs in animals with much higher frequency. The causative organisms constitute a diverse group of clostridia, resulting in nomenclature problems. Human botulism is largely limited to toxin types A, B, and E, while type C botulism predominates in avian and nonhuman mammalian species. The diagnosis of botulism is made on the basis of the neurologic signs and symptoms that it causes in humans and animals. The diagnosis is confirmed by tests that identify the toxin and toxigenic organisms in patient and food specimens. Treatment includes supportive intensive care and use of therapeutic antitoxin.

Entities:  

Mesh:

Year:  1995        PMID: 8542759     DOI: 10.1007/978-3-642-85173-5_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  35 in total

1.  Biodiversity of Clostridium botulinum type E strains isolated from fish and fishery products.

Authors:  E Hyytiä; S Hielm; J Björkroth; H Korkeala
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

2.  Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.

Authors:  Daniel M Held; Amy C Shurtleff; Scott Fields; Christopher Green; Julie Fong; Russell G A Jones; Dorothea Sesardic; Roland Buelow; Rae Lyn Burke
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

4.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

6.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  A case of botulism due to an infected traumatic injury.

Authors:  R Romanello; F De Santis; R Caione; L Fenicia; P Aureli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

8.  Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains.

Authors:  Giovanna Franciosa; Francesca Floridi; Antonella Maugliani; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

9.  Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approach.

Authors:  Mari Nevas; Miia Lindström; Sebastian Hielm; K Johanna Björkroth; Michael W Peck; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

10.  Identification of type A, B, E, and F botulinum neurotoxin genes and of botulinum neurotoxigenic clostridia by denaturing high-performance liquid chromatography.

Authors:  Giovanna Franciosa; Manoocheher Pourshaban; Alessandro De Luca; Anna Buccino; Bruno Dallapiccola; Paolo Aureli
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.